This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated CENPE Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CENPE WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~316.4 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Positive control | Bronchus (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Methylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M04553-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HepG2 cell lysate (catalog M04553-1) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M04553-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
CENPE is predicted at 316.4 kDa; propeptide cleavage and isoforms could affect migration, but no distinct band size is demonstrated.
| Band near 316.4 kDa | Consistent with the predicted CENPE precursor, pending band-identity controls |
| Band marginally below 316.4 kDa | Could reflect cleavage of the 2699–2701 propeptide, though a resolvable shift is not established |
| Several bands near the predicted size | Isoforms 1 and 3 are possible contributors, but distinct migration is not established |
| One band without a resolved doublet | Compatible with isoforms whose migration is not known to differ |
| Predicted precursor mass | Places the full-length CENPE reference near 316.4 kDa |
| Propeptide at residues 2699–2701 | Cleavage would remove three residues; a resolvable shift is not established |
| Isoform 1 | Its apparent size relative to isoform 3 is not supplied |
| Isoform 3 | Its apparent size relative to isoform 1 is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | CENPE is associated with kinetochores and the mitotic spindle | Check sample quality and compare mitotic enrichment with an appropriate positive control |
| Band higher than expected | No supplied feature establishes an upward shift | Check size markers and verify band identity by CENPE depletion |
| Band lower than expected | Propeptide cleavage removes only three residues; a substantial shift has no established cause | Check band identity by CENPE depletion and assess sample degradation |
| Multiple bands | Isoforms 1 and 3 are annotated, but distinct migration is unproven | Test which bands respond to CENPE depletion |
| Weak or no signal | CENPE localization to kinetochores and spindle may limit signal in the sampled cells | Check loading, antibody performance, and a mitotic positive control |
| Fragments below expected size | Protein breakdown is possible; fragment masses are not supplied | Use protease inhibitors and verify CENPE identity by depletion |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | High | Protein (IHC) | HPA → |
| Epididymis | glandular cells | High | Protein (IHC) | HPA → |
| Kidney | distal tubules | High | Protein (IHC) | HPA → |
| Nasopharynx | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | Not detected | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for CENPE, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-CENPE antibody for Western blot: M04553-1, a monoclonal antibody with stated human reactivity. Its WB image shows CENPE expression in HepG2 cell lysate; evidence for other samples is not supplied.
Which to pick: M04553-1 is the only listed option. It has a WB image from HepG2 cell lysate and stated human reactivity; assess suitability for other sample types separately.